A bacteria-targeted MR contrast agent, Zn-, consisting of two Zn-dipicolylamine (Zn-dpa) groups conjugated to a Gd chelate has been synthesized and characterized. In vitro studies with and show that Zn- exhibits a significant improvement in bacteria labeling efficiency vs. control. Studies with a structural analogue, Zn-, indicate that removal of one Zn-dpa moiety dramatically reduces the agent's affinity for bacteria. The ability of Zn- to significantly reduce the of labeled vs. unlabeled bacteria, resulting in enhanced MR image contrast, demonstrates its potential for visualizing bacterial infections in vivo.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634600 | PMC |
http://dx.doi.org/10.1002/ejic.201101362 | DOI Listing |
Eur J Nucl Med Mol Imaging
November 2024
Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713GZ, The Netherlands.
Introduction: Bacterial infections pose major challenges in medicine. To guide effective infection treatment, faster and more accurate diagnostic modalities are needed. Bacteria-targeted molecular imaging can meet these needs.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
July 2024
Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713GZ, The Netherlands.
Introduction: Bacterial infections are a major problem in medicine, and the rapid and accurate detection of such infections is essential for optimal patient outcome. Bacterial infections can be diagnosed by nuclear imaging, but most currently available modalities are unable to discriminate infection from sterile inflammation. Bacteria-targeted positron emission tomography (PET) tracers have the potential to overcome this hurdle.
View Article and Find Full Text PDFACS Appl Bio Mater
May 2021
Cixi Institute of Biomedical Engineering, Chinese Academy of Sciences (CAS) Key Laboratory of Magnetic Materials and Devices & Zhejiang Engineering Research Center for Biomedical Materials, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, People's Republic of China.
Bacterial infections are one of the most serious health risks worldwide, and their rapid diagnosis remains a major challenge in clinic. To enhance the relaxivity and bacterial specificity of magnetic resonance imaging (MRI) contrast agents, here, a kind of gadolinium-based nanoparticles (NPs) of impressive biocompatibility is constructed as a contrast agent for maltodextrin-mediated bacteria-targeted diagnosis. To realize this, positively charged ultrasmall gadolinium oxide (GdO, 2-3 nm) NPs are embedded in mesoporous silica NPs (MSN) with pore size around 6.
View Article and Find Full Text PDFEur J Inorg Chem
April 2012
Departments of Chemistry, Molecular Biosciences, Neurobiology, Biomedical Engineering, and Radiology, Northwestern University, 2145 Sheridan Rd., Evanston, IL 60208, USA.
A bacteria-targeted MR contrast agent, Zn-, consisting of two Zn-dipicolylamine (Zn-dpa) groups conjugated to a Gd chelate has been synthesized and characterized. In vitro studies with and show that Zn- exhibits a significant improvement in bacteria labeling efficiency vs. control.
View Article and Find Full Text PDFCytometry A
October 2011
Chemistry Department, M.V. Lomonosov Moscow State University, Moscow, Russia.
Recently, photoacoustic (PA) flow cytometry (PAFC) has been developed for in vivo detection of circulating tumor cells and bacteria targeted by nanoparticles. Here, we propose multispectral PAFC with multiple dyes having distinctive absorption spectra as multicolor PA contrast agents. As a first step of our proof-of-concept, we characterized high-speed PAFC capability to monitor the clearance of three dyes (Indocyanine Green [ICG], Methylene Blue [MB], and Trypan Blue [TB]) in an animal model in vivo and in real time.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!